EN 
FR The team unites unparalleled, world-renowned experts in AI, biomarker discovery, drug development, biopharma, and healthcare innovation.
Alexandre
Le Bouthillier, PhD
Partner & CEO
- Serial entrepreneur in AI (exit @27x)
- Angel investor in 15 startups
- Board (Mila (honorific), IVADO, Mtl InVivo, MEDTEQ+, QIS, EnvisAGE)
Jacques Corbeil, Ph.D.
Partner & CSO
- Canada Research Chair in Medical Genomics + Member MILA
- Canadian Senate Medal recipient
-
Expert in AI + Omics
Scientific committees IVADO, Sorbonne AI Center
Manon Boisclair, MS, MBA
Partner
- Global BioPharma exec, commercialized 5 oncology blockbusters
- Angel investor in 17 startups
- Board (Canadian Cancer Society, Gray, Oncology)
Claudia Carpentier, PhD
Dir. Operations
- Chemical scientist working at the intersection of metabolomics and bioinformatics
- Metabolomic analysis for biomarker discovery and clinical research
Yoshua Bengio, PhD
AI Advisor
- Modern AI co-father
- Mila Founder (World's largest AI research institute)
- A.M. Turing Award recipient
David Wishart, PhD
Metabolomics Advisor
- Creator of the world human metabolome database
- 8 metabolomics labs in Canada
- Most highly cited scientist in Metabolomics
John Reichenbach, MBA
BioHub / Finance Advisor
- Seasoned Investor in Boston
- Founder Harvard Business School - Angel Group
ABOUT lINEARIS
Linearis is transforming healthcare by merging artificial intelligence and biomarker analysis to enhance patient care with more precise, accessible prevention, detection, treatment of metabolic diseases including cancer, diabetes, and antimicrobial resistance.